Literature DB >> 17276300

Cardiac magnetic resonance versus SPECT: are all noninfarct myocardial regions created equal?

Vasken Dilsizian.   

Abstract

Mesh：

Year:  2007        PMID： 17276300     DOI： 10.1016/j.nuclcard.2006.12.143

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  22 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

2.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation.

Authors:  K A Reimer; R B Jennings
Journal:  Circulation       Date:  1979-10       Impact factor: 29.690

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model.

Authors:  Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

6.  Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.

Authors:  P Perrone-Filardi; L Pace; M Prastaro; F Squame; S Betocchi; A Soricelli; F Piscione; C Indolfi; T Crisci; M Salvatore; M Chiariello
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

7.  [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?

Authors:  G Srinivasan; A N Kitsiou; S L Bacharach; M L Bartlett; C Miller-Davis; V Dilsizian
Journal:  Circulation       Date:  1998-03-10       Impact factor: 29.690

8.  Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization?

Authors:  A N Kitsiou; G Srinivasan; A A Quyyumi; R M Summers; S L Bacharach; V Dilsizian
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

9.  Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction.

Authors:  W J Rogers; C M Kramer; G Geskin; Y L Hu; T M Theobald; D A Vido; S Petruolo; N Reichek
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

10.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245
View more
  7 in total

Review 1.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 2.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

3.  The emergence of MRI and MSCT cardiac imaging: nuclear cardiology is not the only actor on the stage.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05       Impact factor: 9.236

Review 4.  Updates on Stress Imaging Testing and Myocardial Viability With Advanced Imaging Modalities.

Authors:  Sandeep S Hedgire; Michael Osborne; Daniel J Verdini; Brian B Ghoshhajra
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

Review 5.  Multimodality imaging in the assessment of myocardial viability.

Authors:  Sara L Partington; Raymond Y Kwong; Sharmila Dorbala
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

Review 6.  Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.

Authors:  Shahbudin H Rahimtoola; Vasken Dilsizian; Christopher M Kramer; Thomas H Marwick; Jean-Louis J Vanoverschelde
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

Review 7.  The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.

Authors:  Partho P Sengupta; Christopher M Kramer; Jagat Narula; Vasken Dilsizian
Journal:  JACC Cardiovasc Imaging       Date:  2017-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.